An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This clinical trial objective is to investigate the safety and efficacy of GK567 to alleviate
malodour of foul smelling, anaerobically infected fungating neoplastic tumours, over 14 days
of treatment.
The clinical hypothesis is that the success rate is no worse than 70% in the population of
interest, where success for a patient is defined as a smell score of 0 or 1 at Day 14/end of
treatment, as assessed by the Study Investigator.